Comerica Bank’s Standard BioTools LAB Stock Holding History

Comerica Bank’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.62K	Buy	2,829 +278	+11%	+$373	﹤0.01%	3462
2025 Q3	$3.32K	Sell	2,551 -170	-6%	-$223	﹤0.01%	3469
2025 Q2	$3.27K	Buy	2,721 +333	+14%	+$369	﹤0.01%	3434
2025 Q1	$2.58K	Buy	2,388 +332	+16%	+$466	﹤0.01%	3436
2024 Q4	$3.6K	Sell	2,056 -357	-15%	-$665	﹤0.01%	3381
2024 Q3	$4.66K	Buy	2,413 +195	+9%	+$382	﹤0.01%	3355
2024 Q2	$3.93K	Buy	2,218 +820	+59%	+$2K	﹤0.01%	3352
2024 Q1	$3.79K	Buy	1,398 +119	+9%	+$287	﹤0.01%	3393
2023 Q4	$2.83K	Buy	1,279 +118	+10%	+$252	﹤0.01%	3445
2023 Q3	$3.37K	Buy	+1,161	New	+$3.04K	﹤0.01%	3463

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Comerica Bank's LAB Position: Q4 2025 in Review

Comerica Bank increased its Standard BioTools (LAB) stake by 11% in Q4 2025, buying an estimated $373 and bringing the position to 2,829 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3462.

Comerica Bank first reported a position in LAB in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.66K in Q3 2024. 159 funds tracked by Wall St. Rank hold LAB as of Q4 2025.

Comerica Bank held 2,829 shares of Standard BioTools worth $3.62K as of Q4 2025.
Comerica Bank bought 278 Standard BioTools shares in Q4 2025, an estimated $373.
Standard BioTools made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3462 holding.
Comerica Bank first reported a position in Standard BioTools in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Standard BioTools position peaked at $4.66K in Q3 2024.
159 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.